Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes.

While these measures did not reach statistical significance in this small study, they were considered clinically meaningful and were further supported by post hoc analyses that showed histological improvement correlated with reductions in rectal bleeding with GLPG3970 compared with placebo.

also in 111,027 other papers